Search

The liver coordinates over 500 biochemical processes crucial for maintaining homeostasis, detoxification, and metabolism. Its specialized cells, arranged in hexagonal lobules, enable it to function as a highly efficient metabolic engine. However, diseases such as cirrhosis, fatty liver disease, and hepatitis present significant global health challenges. Traditional drug development is expensive and often ineffective at predicting human responses, driving interest in advanced in vitro liver models utilizing 3D bioprinting and microfluidics. These models strive to mimic the liver's complex microenvironment, improving drug screening and disease research. Despite its resilience, the liver is vulnerable to chronic illnesses, injuries, and cancers, leading to millions of deaths annually. Organ shortages hinder liver transplantation, highlighting the need for alternative treatments. Tissue engineering, employing polymer-based scaffolds and 3D bioprinting, shows promise. This review examines these innovative strategies, including liver organoids and liver tissue-on-chip technologies, to address the challenges of liver diseases. [ABSTRACT FROM AUTHOR]

Though chitosan hydrogels have shown potential for numerous tissue regeneration applications, its insolubility above pH 6.0 have greatly limited applicability in encapsulation of live cells and pH sensitive bioactive agents. In this report an approach to overcome this limitation was tested with phosphorylated derivative of chitosan, N-methylene phosphonic chitosan (NMPC). NMPC is also known to possess efficacious gene delivery, biomineralization, and osteoinduction properties. NMPC hydrogels were synthesized by cross-linking NMPC with either glutaraldehyde (NMPC-GLU) or genipin (NMPC-GEN). An increase in pH from 3.0 to 6.8 reduced gelation time with both the agents, with the reduction more pronounced in NMPC-GLU. The results correlated with the reaction mechanisms of both agents with NMPC. Further NMPC-GEN gels demonstrated higher elastic modulus and compressive strength values. Cell culture studies showed higher cell proliferation on NMPC-GEN compared to NMPC-GLU. [Supplementary materials are available for this article. Go to the Publisher's online edition ofSoft Materialsfor the following free supplemental resource(s): Supporting information of Pallab Datta et al.] [ABSTRACT FROM AUTHOR]

Hydrogels have evolved over the last decade as materials of choice in varied biomedical applications. This is associated with the inherent biocompatible nature of the hydrogels. The modulation of the properties of the hydrogels is easily possible due to the availability of polymers of varied chemistry and physical properties. This review discusses the pharmaceutical aspects of the controlled release of bioactive agents from hydrogel-based formulations. [ABSTRACT FROM PUBLISHER]

In recent years, chitosan, a biocompatible natural polymer, having a cellulosic backbone has gained importance in various biomedical applications like wound healing, tissue engineering, surface modifications of implantable devices, and drug delivery. This may be attributed to the versatile chemistry of the polymer. Various chitosan-mediated delivery systems have been developed to improve the bioavailability of drug(s) and be categorized either as nanoparticulate, microparticulate, or macro delivery systems. All these delivery systems have their own advantages and limitation as a delivery vehicle. This review gives an overview of the chitosan-based drug delivery systems. [ABSTRACT FROM AUTHOR]